PathnSitu Biotechnologies

Your Advanced Tissue Pathology Partner

PathnSitu Biotechnologies is a leading company in the supply of high-quality immunohistochemistry products for tissue-based Cancer Diagnosis.We provide highly specific and sensitive Antibodies, Detection Kits, Histology Special Stains, Instruments, Reagents, Buffers, Antibody Diluents, Positively Charged Slides and all the Ancillaries required for Immunohistochemistry helping Pathologists and Cancer Research Laboratories with an accurate Histology-based Cancer Diagnosis.

Our Products

Videos

Latest News, Events & Blogs

September 24, 2026

Tumor Tissue: Types, Characteristics, and How It Is Evaluated in Cancer Diagnosis

Tumor tissue is central to cancer diagnosis, from specimen collection and tissue processing to microscopic evaluation, IHC, and biomarker testing. Learn how tumor tissue differs from normal tissue, how it is examined, and why tissue quality and preservation matter for accurate diagnosis and testing.

Learn More
September 23, 2026

Myeloproliferative Neoplasms and the Role of IHC: Inside the PathnSitu MPN Panel

Discover how immunohistochemistry supports the evaluation of myeloproliferative neoplasms through the PathnSitu MPN Panel. Explore CD34, CD117, CD41, MPO and Glycophorin A for assessing key hematopoietic and myeloid compartments alongside morphology and molecular findings.

Learn More
September 23, 2026

PathnSitu Blood Cancer IHC Panel: From Biomarker Identification to Digital Visualization

PathnSitus Blood Cancer IHC Panel supports the evaluation of hematological malignancies by combining lineage and differentiation markers such as CD45, CD3, CD20, CD79a, PAX5, MPO, CD34, TdT and CD138. The workflow extends from MERS i antigen retrieval and Caliber30 automated IHC staining to digital microscopy and scanning, supporting a connected approach to tissue preparation, biomarker staining and visualization.

Learn More

Contact

get in touch with us

Have an enquiry or a product in mind or an idea to discuss
and explore? Write to us.